Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00416312 · OUTCOME

Tumor Absorbed Dose

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma · Source last updated 2018-08-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Gy
Interval / dispersion
Standard Deviation
Time frame
up to 4 years

What was measured

tumor absorbed dose (Gy)

Groups in this outcome

Conventional & Patient-specific Dosimetry

Tumor absorbed dose calculations determined using both conventional dosimetry and 3D-RD patient-specific dosimetry software.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Conventional & Patient-specific Dosimetry7

Analysis denominator · tumor

GroupSource count
Conventional & Patient-specific Dosimetry7

Reported measurements

Conventional dosimetry
Values in Gy · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Conventional & Patient-specific Dosimetry3.013.04Not reportedNot reportedNot reported
Patient-specific dosimetry
Values in Gy · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Conventional & Patient-specific Dosimetry3.413.1Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        3.04
        value
        3.01
    title
    Conventional dosimetry
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        3.1
        value
        3.41
    title
    Patient-specific dosimetry
denom Units Selected
tumor
denoms
  1. counts
    1. group Id
      OG000
      value
      7
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      7
    units
    tumor
description
tumor absorbed dose (Gy)
dispersion Type
Standard Deviation
groups
  1. description
    Tumor absorbed dose calculations determined using both conventional dosimetry and 3D-RD patient-specific dosimetry software.
    id
    OG000
    title
    Conventional & Patient-specific Dosimetry
param Type
MEAN
reporting Status
POSTED
time Frame
up to 4 years
title
Tumor Absorbed Dose
type
PRIMARY
type Units Analyzed
tumor
unit Of Measure
Gy

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice